{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T05:20:04Z","timestamp":1700025604565},"reference-count":40,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2006,11,10]],"date-time":"2006-11-10T00:00:00Z","timestamp":1163116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Geriat Psychiatry"],"published-print":{"date-parts":[[2007,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Rationale<\/jats:title><jats:p>Quetiapine was approved in Germany as an atypical antipsychotic for treatment of schizophrenia in 2000, followed by the approval as an antipsychotic for treatment of bipolar mania in 2003. The approval of quetiapine for treatment of bipolar depression is expected. We hypothesized that the psychogeriatric prescription pattern for quetiapine shifts from the psychotic to the affective spectrum.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Retrospectively we screened discharge reports of all geriatric inpatients of the psychiatric department of the Ruhr\u2010University of Bochum in the period from January 2001 until March 2006 and identified 208 individual patients aged over 60 years, who had received quetiapine as final medication. Age, gender, daily drug dose, year of treatment and diagnosis (according to ICD\u201010) were recorded and analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Over the six\u2010year time span, the proportion of affective disorders (F3) as indication for quetiapine in the elderly increased, whereas the proportion of dementia (F0) as indication for quetiapine decreased significantly. The proportion of schizophrenic disorders (F2) treated with quetiapine did not change significantly.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Since the decision of the German Federal Court in 2002 \u2018off label\u2019 use goes to the expenses of the prescriber. So the decrease of quetiapine in dementia is probably due to its \u2018off label\u2019 status in dementia. The psychogeriatric indication shift for quetiapine towards affective disorders could be the consequence of good clinical experiences with the drug and growing evidence for its antidepressant effect.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In addition to controlled pharmacological trials prospective clinical research is needed to evaluate the prescription attitudes of clinicians. Copyright \u00a9 2006 John Wiley &amp; Sons, Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/gps.1687","type":"journal-article","created":{"date-parts":[[2006,11,10]],"date-time":"2006-11-10T11:46:54Z","timestamp":1163159214000},"page":"401-404","source":"Crossref","is-referenced-by-count":6,"title":["Quetiapine indication shift in the elderly: diagnosis and dosage in 208 psychogeriatric patients from 2000 to 2006"],"prefix":"10.1002","volume":"22","author":[{"given":"Lorenz","family":"Hilwerling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Juckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan Georg","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,11,10]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.537"},{"key":"e_1_2_1_3_1","first-page":"209","article-title":"Priapism associated with quetiapine in an elderly patient","volume":"3","author":"Andres M","year":"2006","journal-title":"Actas Esp Psiquiatr"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(97)00190-X"},{"key":"e_1_2_1_5_1","unstructured":"BallardC WaiteJ.2006.The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's desease. In Cochrane Database Syst Rev CD003476."},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1478951505050352"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G564"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.7.1351"},{"key":"e_1_2_1_9_1","first-page":"138","article-title":"Pharmacotherapy of behavioral and psychological symptoms of dementia: a review of atypical antipsychotics","volume":"2","author":"Daiello LA","year":"2003","journal-title":"Consult Pharm"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200620050-00009"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145704004705"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200015030-00001"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610205002280"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1159\/000077367"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0420f"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n1106"},{"key":"e_1_2_1_17_1","first-page":"31","article-title":"Review of quetiapine side effects","volume":"61","author":"Garver DL.","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.4140\/TCP.n.2004.809"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajgp.11.6.694"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200443140-00005"},{"key":"e_1_2_1_21_1","first-page":"21","article-title":"Tardive dyskinesia rates with atypical antipsychotics in older adults","volume":"65","author":"Jeste DV.","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/0891988702250533"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-828464"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0619"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2006.02.007"},{"key":"e_1_2_1_26_1","first-page":"43","article-title":"Side effects of antipsychotics in the elderly","volume":"61","author":"Masand PS.","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079904X2312"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20474"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1016"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.559"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2005.04.024"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0401"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.7.7.929"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000186870.75042.25"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200501000-00007"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.JGP.0000200589.01396.6d"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000166405.49473.70"},{"key":"e_1_2_1_38_1","first-page":"11","article-title":"Efficacy of atypical antipsychotics in elderly patients with dementia","volume":"65","author":"Tariot PN","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X46340"},{"key":"e_1_2_1_40_1","first-page":"123","article-title":"Update on the biological treatment of aggression","volume":"2","author":"Volavka J","year":"2006","journal-title":"Actas Esp Psiquiatr"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2003.01.001"}],"container-title":["International Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fgps.1687","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/gps.1687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T04:32:00Z","timestamp":1700022720000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/gps.1687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,10]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["10.1002\/gps.1687"],"URL":"https:\/\/doi.org\/10.1002\/gps.1687","archive":["Portico"],"relation":{},"ISSN":["0885-6230","1099-1166"],"issn-type":[{"value":"0885-6230","type":"print"},{"value":"1099-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,10]]}}}